Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Botulinum Toxin Type A Treatment of Disabling Migraine Headaches: A Randomized, Double-Blind, Placebo-Controlled Study
005
Authors/Disclosures
Fidel Meira, MD (Hospital Madre Teresa) No disclosure on file
No disclosure on file
Shabnam Pakneshan, MD (henry Ford Medical group) No disclosure on file
Evanthia Bernitsas, MD, FÂ鶹´«Ã½Ó³»­ (Wayne State School of Medicine) Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.